NCT02685943

Brief Summary

Although suicide risk is highly prevalent among the patient population in mental health care, remarkably little research exists on effective treatments. Among a small set of novel approaches, CAMS is particularly promising. The investigators compare CAMS to TAU in a randomized controlled trial at four departments in Vestre Viken Hospital Trust, hypothesizing CAMS to be the superior approach. Primary outcome measures are suicidal ideation and suicide attempts, with secondary outcome measures including general symptoms of mental health problems. Changes in the outcome measures are compared between the two groups from baseline to 6 and 12 months after patients are included in the study. The study has the potential to impact the science of treating suicidal individuals and it could benefit the general public by establishing CAMS as an effective clinical approach for rapidly reducing suicide risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 19, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

April 19, 2021

Status Verified

April 1, 2021

Enrollment Period

4 years

First QC Date

February 8, 2016

Last Update Submit

April 13, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in scores on Beck's Scale for Suicide Ideation (BSSI)

    Interview scale with 19 items that measures a patient's suicidal ideation at its worst point in the past 2 weeks.

    From baseline to 6 and 12 months after patient is included in the study

Secondary Outcomes (3)

  • Changes in scores on The Outcome Questionaire 45 (OQ-45)

    From baseline to 6 and 12 months after patient is included in the study

  • Norwegian Patient Registry (NPR) data

    Yearly for five years after study inclusion

  • Changes in scores on Suicide Attempt Self-Injury Count (SASI-C)

    changes from baseline to 6 and 12 months after patient is included in the study

Study Arms (2)

CAMS treatment

EXPERIMENTAL

Psychotherapy using the Collaborative Assessment and Management of Suicidality framework

Behavioral: Psychotherapy

Treatment as usual

ACTIVE COMPARATOR

Ordinary treatment for suicidal patients

Behavioral: Psychotherapy

Interventions

PsychotherapyBEHAVIORAL
CAMS treatmentTreatment as usual

Eligibility Criteria

Age18 Months+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Significant suicide ideation on Beck's Scale for Suicide Ideation (score 13 and above). Informed consent to participate.

You may not qualify if:

  • Active psychosis, cognitive or physical impairment or other problems that preclude the ability to understand the study procedures and provide informed consent, non-Norwegian speaking subjects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vestre Viken Helseforetak

Drammen, 3004, Norway

Location

Related Publications (3)

  • Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.

  • Storebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.

  • Ryberg W, Fosse R, Zahl PH, Brorson I, Moller P, Landro NI, Jobes D. Collaborative Assessment and Management of Suicidality (CAMS) compared to treatment as usual (TAU) for suicidal patients: study protocol for a randomized controlled trial. Trials. 2016 Oct 3;17(1):481. doi: 10.1186/s13063-016-1602-z.

MeSH Terms

Conditions

Suicidal IdeationSuicide, AttemptedSuicide

Interventions

Psychotherapy

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities

Study Officials

  • Roar Fosse, Ph.D.

    Division of mental health and addiction, Vestre Viken

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2016

First Posted

February 19, 2016

Study Start

April 1, 2015

Primary Completion

April 1, 2019

Study Completion

October 1, 2019

Last Updated

April 19, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Individual patient data will not be shared/ published

Locations